Ninety One (UK)’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
Ninety One (UK)'s EW Position: Q3 2026 in Review
Ninety One (UK) reduced its Edwards Lifesciences (EW) stake by 3.2% in Q3 2026, selling an estimated $35M and leaving 11,943,675 shares worth $1.03B. The position accounts for 2.27% of the portfolio, ranked #10.
Ninety One (UK) first reported a position in EW in Q2 2023 and has held it in 14 quarters since. The position peaked at $1.12B in Q2 2026. 297 funds tracked by Wall St. Rank hold EW as of Q3 2026.
- Ninety One (UK) held 11,943,675 shares of Edwards Lifesciences worth $1.03B as of Q3 2026.
- Ninety One (UK) sold 393,827 Edwards Lifesciences shares in Q3 2026, an estimated $35M.
- Edwards Lifesciences made up 2.27% of Ninety One (UK)'s portfolio in Q3 2026, its #10 holding.
- Ninety One (UK) first reported a position in Edwards Lifesciences in Q2 2023 and has held it in 14 quarters since.
- Ninety One (UK)'s Edwards Lifesciences position peaked at $1.12B in Q2 2026.
- 297 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.
Based on Ninety One (UK)'s 13F filing for Q3 2026, filed 15 Oct 2026.